Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Calcium signaling pathway | R-HSA-381753 | map04020 | sulfamerazine | 5853 | drug-path |
| Type II diabetes mellitus | R-HSA-2127377 | map04930 | sulfamerazine | 5853 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | sulfamerazine | 5853 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | sulfamerazine | 5853 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | sulfamerazine | 5853 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | sulfamerazine | 5853 | drug-path |
| Cardiac muscle contraction | R-HSA-397014 | map04260 | sulfamerazine | 5853 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | sulfamerazine | 5853 | drug-path |
| Proteasome | R-HSA-68819 | map03050 | sulfamerazine | 5853 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | bromopride | 2446 | drug-path |
| Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | bromopride | 2446 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | bromopride | 2446 | drug-path |
| Wnt signaling pathway | R-HSA-195721 | map04310 | bromopride | 2446 | drug-path |
| T cell receptor signaling pathway | R-HSA-983705 | map04660 | bromopride | 2446 | drug-path |
| Insulin signaling pathway | R-HSA-74752 | map04910 | bromopride | 2446 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | bromopride | 2446 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | bromopride | 2446 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | bromopride | 2446 | drug-path |
| Cell cycle | R-HSA-1640170 | map04110 | bromopride | 2446 | drug-path |
| Long-term potentiation | R-HSA-9620244 | map04720 | bromopride | 2446 | drug-path |